C4 Therapeutics share price logo

C4 Therapeutics

NASDAQ: CCCC

Small Cap

$4.17

-0.09

(-2.11%)

Live

as on

C4 Therapeutics Stock Performance

as on August 19, 2026 at 3:26 am IST

  • Day's Low

    Day's High

    $4.11
    $4.30
    downward going graph

    1.44%

    Downside

    3.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.69
    $5.17
    downward going graph

    59.47%

    Downside

    23.98%

    Upside

    downward going graph

C4 Therapeutics share price movements today

Previous Close
$4.26
Open
$4.20
Volume
1.7M
Market Cap
$521.6M
Day's Low - High
$4.11 - $4.30
52 Week Low - High
$1.69 - $5.17

C4 Therapeutics Historical Returns

1 Month Return
+ 14.91 %
3 Month Return
+ 19.1 %
1 Year Return
+ 72.36 %
3 Year Return
+ 28.1 %
5 Year Return
-89.31 %

C4 Therapeutics Stock Fundamentals & Key Indicators

Check C4 Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$521.6M

EPS (TTM)

-1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.08

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.08894926143107651

EBITDA

-98.3M

Revenue (TTM)

35.0M

Profit Margin

94.86%

Return On Equity TTM

-45.45%

C4 Therapeutics Stock Valuation

Track how C4 Therapeutics P/E has moved over time to understand its valuation trends.

C4 Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-17.67x)

December 31, 2021

Industry (-7.28x)

December 31, 2025

Today (-1.50x)

December 31, 2025

Highest (-1.50x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.50x

C4 Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of C4 Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$521.6M-89.31%-4.0894.86%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for C4 Therapeutics Stock including INR - Dollar returns

The C4 Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

C4 Therapeutics investment value today

Current value as on today

₹1,85,741

Returns

₹85,741

(+85.74%)

Returns from C4 Therapeutics Stock

₹69,512 (+69.51%)

Dollar Impact

₹16,229 (+16.23%)

Analyst Recommendation on C4 Therapeutics Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for C4 Therapeutics. Average target price of $13.33

C4 Therapeutics Share Price Target

Get share price movements and forecasts by analysts on C4 Therapeutics.

What analysts predicted

68.72%UPSIDE

Target Price

$13.33

Current Price

$4.17

Analyzed by

3 Analysts

Target

$13.33

C4 Therapeutics target price $13.33, a slight upside of 68.72% compared to current price of $4.17. According to 3 analysts rating.

Indian Investors' Interest in C4 Therapeutics Stock

Search interest for C4 Therapeutics Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

C4 Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
3
12
5
7
6
11
11
6
6
Gross Profit
1
3
9
3
7
6
11
11
4
6
Operating Income
-37
-32
-21
-37
-29
-28
-34
-23
-27
-26
EBITDA
-32
-29
-15
-32
-25
-25
-31
-19
-23
-23
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
0
2
1
0
0
0
0
1
0
Income Before Tax
-34
-28
-17
-34
-26
-26
-32
-20
-25
-23
Income Tax Expense
0
-
-
0
-
-
-
0
-
-
Net Income
-34
-28
-17
-34
-26
-26
-32
-20
-25
-23
Net Profit Margin
48.14%
100.00%
82.97%
86.62%
100.00%
100.00%
100.00%
100.00%
70.72%
100.00%

C4 Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
19
21
33
45
31
20
35
35
Gross Profit
-9
21
-45
45
31
13
35
27
Operating Income
-16
-35
-60
-82
-129
-139
-119
-104
EBITDA
-15
-31
-58
-80
-124
-122
-103
-102
Interest Expense
-
-
1
2
2
1
-
-
Depreciation
3
1
1
1
1
7
1
1
Income Before Tax
-15
-33
-65
-83
-128
-131
-105
-104
Income Tax Expense
-
0
0
-
-
1
0
0
Net Income
-15
-34
-66
-83
-128
-132
-105
-104
Net Profit Margin
-47.66%
100.00%
-136.30%
100.00%
100.00%
62.72%
100.00%
77.81%

C4 Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-34
-28
-17
-34
-26
-26
-32
-20
-25
-23
Operating Cash Flow
-24
-18
-4
-17
-33
-12
-31
-22
-29
-1
Investing Cash Flow
31
-53
-11
13
29
38
4
-80
16
-14
Financing Cash Flow
57
34
0
0
0
-
7
118
0
33
Change in Cash
65
-36
-16
-4
-4
26
-19
15
-13
17

C4 Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-34
-66
-83
-128
-132
-105
-104
Operating Cash Flow
-16
55
-67
-86
-105
-106
-65
-98
Investing Cash Flow
36
-1
-190
-189
58
158
-51
-8
Financing Cash Flow
1
0
348
171
1
45
45
126
Change in Cash
21
54
91
-104
-46
97
-71
19

Mutual Funds that own C4 Therapeutics Stock

Check out the Mutual Funds with significant holdings in C4 Therapeutics.

Funds
Holdings
Shares Held
WASATCH FUNDS TRUST
3.470284%
4269322
VANGUARD INDEX FUNDS
3.068768%
3775357
Fidelity Concord Street Trust
0.591276%
727419
DFA INVESTMENT DIMENSIONS GROUP INC
0.159964%
196796
Bridgeway Funds, Inc.
0.097541%
120000

Global Institutional Holdings in C4 Therapeutics

Funds
Holdings
Peter Kolchinsky
6.5%
Vanguard
4.39%
iShares
3.85%
Fidelity
0.79%
Dimensional
0.47%

Insights on C4 Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CCCC stock has moved up by 10.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 6.15M → 6.64M (in $), with an average increase of 7.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -25.12M → -23.63M (in $), with an average increase of 6.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 432.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 583.7%

About C4 Therapeutics

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targeting IKZF1 and IKZF3, or IKZF1/3 to address a need across multiple lines of therapy in multiple myeloma, which has competed its phase 1. The company is also developing oncology product candidate, CFT8919, an orally bioavailable, allosteric, mutant-selective bidac degrader of epidermal growth factor receptor, with an L858R mutation in non-small cell lung cancer; and new degraders focused on inflammation, neuroinflammation, and neurodegeneration. It has strategic collaborations F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Betta Pharmaceuticals Co. Ltd., and Merck KGAA. Additionally, it has a collaboration agreement with Roche Holding AG for the development of Degrader-Antibody Conjugates for cancer treatment. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
OrganisationC4 Therapeutics
Headquarters490 Arsenal Way, Watertown, MA, United States, 02472
IndustryBiotechnology
CEOMr. Andrew J. Hirsch M.B.A.
E-voting on sharesClick here to vote

Key Management of C4 Therapeutics

Name

Title

Ms. Kelly A. Schick

Chief People Officer

Dr. Isabel Chiu Ph.D.

Senior Vice President of Strategic Alliances & Business Development

Mr. Andrew J. Hirsch M.B.A.

CEO, President & Director

Ms. Kendra R. Adams

Principal Accounting Officer, CFO, Head of Corporate Affairs & Treasurer

Ms. Courtney Solberg

Senior Manager of Investor Relations

Dr. Christopher Nasveschuk

Senior Vice President of Chemistry

Mr. Roy Pollock Ph.D.

Senior Vice President of Biological Sciences

Dr. Kenneth C. Anderson M.D., Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Dr. Leonard M. J. Reyno M.D.

Chief Medical Officer

Dr. Nathanael S. Gray Ph.D.

Co-Founder & Member of Scientific Advisory Board

FAQs

What is C4 Therapeutics share price today?

C4 Therapeutics share price today is $4.17 as on . C4 Therapeutics share today touched a day high of $4.30 and a low of $4.11.

What is the 52 week high and 52 week low for C4 Therapeutics share?

C4 Therapeutics share touched a 52 week high of $5.17 on and a 52 week low of $1.69 on . C4 Therapeutics stock price today i.e. is trending at $4.17,which is 19.34% down from its 52 week high and 146.73% up from its 52 week low.

What is C4 Therapeutics's market capitalisation today?

C4 Therapeutics market capitalisation is $0.00T as on .

How to invest in C4 Therapeutics Stock (CCCC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for C4 Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in C4 Therapeutics Shares that will get you 0.3597 shares as per C4 Therapeutics share price of $4.17 per share as on August 18, 2026 at 9:56 pm IST.

What is the minimum amount required to buy C4 Therapeutics Stock (CCCC) from India?

Indian investors can start investing in C4 Therapeutics (CCCC) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in C4 Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on C4 Therapeutics share’s latest price of $4.17 as on August 18, 2026 at 9:56 pm IST, you will get 2.3981 shares of C4 Therapeutics. Learn more about fractional shares .

What are the returns that C4 Therapeutics has given to Indian investors in the last 5 years?

C4 Therapeutics stock has given -89.31% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?